Literature DB >> 19951638

Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.

Sophia Benomar1, Saber Boutayeb, Yassir Afifi, Syrine Hamada, Jamila Bouhllab, Badreddine Hassam, Hassan Errihanni.   

Abstract

Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor that is responsible for several cutaneous side effects. We report a case of hand-foot syndrome associated with a papulo-pustular and seborrheic dermatitis-like eruption of the face in a 61-year-old patient treated with erlotinib for lung cancer.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19951638

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN： 1087-2108


  4 in total

1.  Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors.

Authors:  Emmanuelle Faye; Emmanuelle Bondon-Guitton; Pascale Olivier-Abbal; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2013-06-09       Impact factor: 2.953

2.  Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature.

Authors:  Yulong Zheng; Weijia Fang; Nong Xu
Journal:  Oncol Lett       Date:  2012-09-10       Impact factor: 2.967

3.  Dasatinib-induced Seborrheic Dermatitis-like Eruption.

Authors:  Ryan R Riahi; Philip R Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2017-07-01

4.  Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil.

Authors:  Tyler Werbel; Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2018-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.